UC Davis Health's IFM Fund Increases Its Commitment to Delix Therapeutics as At-Home Depression Trial Advances by Jane Richardson November 10, 2026 University Human & Animal Health
UC Davis Health’s IFM Fund Backs Delix Therapeutics in First Investment by Phil Wade September 10, 2025 Advancing Health Worldwide